Publicly listed Daewoong Pharmaceutical has recently unveiled its AI-driven drug development system, powered by a database of hundreds of millions of pre-processed compounds. WHAT IT’S ABOUT
Over the past two years, researchers of the Seoul-based pharma…
Mike Szczesny, Owner & VP of EDCO Awards & Specialties
Influencer marketing in the pharmaceutical industry is a complex issue with reasonable arguments on multiple sides. On the one hand, leveraging individual patients’ personal experiences…
Continue Reading
What You Should Know:
– Cardinal Health (NYSE: CAH) announced a strategic move to bolster its Specialty business with the acquisition of Specialty Networks, a multi-specialty group purchasing and practice enhancement organization, for $1.2 billion…
Continue Reading
Israel-based AION Labs, an AI-enabled drug discovery partnership between global pharma and tech companies, announced the launch of a new startup, TenAces.TenAces will utilize AI, integrating biology and machine learning algorithms, to discover molecular…
Continue Reading
Clinical trials technology company Science 37 went public during the Covid-19 pandemic, a time when drug developers readily embraced technologies that enable patients to participate in drug studies from their homes. Decentralized clinical trials…
Continue Reading
The Lown Institute has released its 2023 Shkreli Awards, highlighting “the worst in healthcare profiteering and dysfunction.” The selection panel includes clinicians, journalists, patient advocates, and health policy experts.
In case anyone doesn’t recognize…
As we kick off 2024, we wanted to start the new year with a series of 2024 Health IT predictions. We asked the Healthcare IT Today community to submit their predictions and we received…
Continue Reading
Top News
Walgreens Boots Alliance is struggling with the performance of primary care chain VillageMD, in which it is the majority shareholder.
Walgreens has closed 27 of the 60 underperforming locations that it previously announced and…
Pharma giant Lily announced the launch of a digital health experience dubbed LilyDirect, which offers patients with diabetes, obesity and migraines access to healthcare providers, educational information and a digital pharmacy for select Lily…
Continue Reading
Diagnostics company LumiraDx announced it signed an agreement to sell its point-of-care technology to pharma giant Roche for $295 million, with an additional payment of $55 million to fund the platform until the acquisition…
Continue Reading
